कृपया अन्य खोज का प्रयास करें
Foresee Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in the United States, China, and Europe. The company’s stabilized injectable formulation pipeline includes FP-001, which completed Phase III clinical study for the treatment of advanced stage prostate cancer; FP-004 that is in preclinical stage to treat opioids use disorder; FP-011 and FP-014, a long-acting sustained release dosage form for the treatment of breast cancer/prostate cancer; and FP-016 for the treatment of neurological diseases. Its new chemical entity pipeline products consist of FP-020 to treat sarcoidosis, idiopathic pulmonary fibrosis, and pulmonary emphysema; FP-025, a selective matrix metalloproteinase-12 inhibitor, which is in Phase II clinical trial for the treatment of asthma, chronic obstructive pulmonary diseases, and acute respiratory distress syndrome in COVID-19 patients; and FP-045, a selective aldehyde dehydrogenase (ALDH2) activator that completed Phase I clinical study for the treatment of fanconi anemia, as well as FP-040, an ALDH2 activator to treat central nervous system diseases. Foresee Pharmaceuticals Co., Ltd. was incorporated in 2013 and is based in Taipei, Taiwan.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Fu-Shiow Yin | - | 2016 | Independent Director |
Daria Mochly-Rosen | - | - | Member of Scientific Advisory Board |
Joseph P. Vacca | - | - | Member of Scientific Advisory Board |
Benjamin Chien | - | 2013 | Founder, CEO & Chairman |
Eric M. Gordon | - | - | Member of Scientific Advisory Board |
Wen-Chi Lee | - | 2016 | Independent Director |
Luo Ming Ling | - | 2015 | Supervisor |
Jia-Long Lee | - | 2015 | Director |
Jeff Wang | - | 2016 | Director |
Vincent Yen | - | 2013 | Representative Director |
Hank Lai | - | 2018 | Independent Director |
Ben Liu | - | 2023 | Independent Director |
Yisheng Lee | - | 2013 | Chief Medical Officer, Acting Head of Clinical Development & Representative Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है